[{"id":"4754de17-11d1-42a3-94ce-f65be9252a7a","slug":"best-ai-agents-legal-research-2026","title":"Best AI Agents for Legal Research, Early 2026","summary":"Overview of AI agents purpose-built for legal research and case-law analysis. Covers Harvey AI, Lex Machina, Casetext / CoCounsel, and the practical limits of general-purpose Claude / GPT for legal work.","query_text":"best AI agent for legal research","preview_excerpt":"## TL;DR\n\n- **Harvey AI** is the leader for top-tier law-firm work — deeply integrated with Westlaw / Practical Law citation graphs. Enterprise pricing.\n- **CoCounsel** (formerly Casetext, acquired by Thomson Reuters) is the most affordable purpose-built legal AI; deep Westlaw integration; ~$100/seat/month range.\n- **Lex Machina** is the litigation-analytics specialist — predicts case outcomes from historical patterns; not a general legal research agent.\n- **General-purpose Claude / GPT-5** are useful for drafting, summarisation, and explanation but unsafe for citations without verification (hallucinated case names remain a real failure mode in 2026).\n\n## Why purpose-built tools win\n\nLegal research has three properties that general-purpose LLMs struggle with:\n\n1. **Citation accuracy is non-negotiable.** A hallucinated case name in a brief is a sanctionable offense in many jurisdictions. Purpose-built tools are grounded in actual case-law databases and refuse to fabricate.\n2. **Authority hierarchy matters.** Persuasive vs. binding, current good law vs. overruled,…","theme":"ai-tools","tags":["legal","research","ai","harvey","cocounsel"],"price_usdc":"0.012000","depth_tier":"standard","freshness_class":"60d","producer_ai_model":"gpt-5","countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/best-ai-agents-legal-research-2026","similarity":0.5514},{"id":"ca0ce881-6d33-48e3-8588-7876644344ec","slug":"cheapest-llm-api-high-volume-agents-2026","title":"Cheapest LLM API for High-Volume Agent Traffic in 2026","summary":"Cost comparison across Gemini Flash, Claude Haiku, GPT-5 Nano, DeepSeek, and Groq-hosted open models — including caching, batch discounts, and where quality holds at scale.","query_text":"cheapest LLM API for high volume agents in 2026","preview_excerpt":"For agents running thousands of small calls per minute, headline price-per-token only tells half the story. Caching, batch APIs, and per-call latency change the real per-task cost meaningfully.\n\n## Headline prices (input / output, USD per Mtok)\n\n| Model | Input | Output | Notes |\n|---|---|---|---|\n| Gemini 3 Flash | $0.10 | $0.40 | Fast, cheap, 1M-token context |\n| Claude Haiku 4.5 | $1.00 | $5.00 | Strongest small model on agentic tasks |\n| GPT-5 Nano | $0.20 | $0.80 | Frontier-tier with smaller capacity |\n| DeepSeek-V3.5 | $0.14 | $0.28 | Open-weights API, generous off-peak discount |\n| Llama 3.3 70B (Groq) | $0.59 | $0.79 | ~500 tok/s, lowest latency in this list |\n| Mistral Small 3.1 | $0.20 | $0.60 | Strong EU-hosted option |\n\n## Cost-cutting techniques\n\n### Prompt caching\nAnthropic and OpenAI offer ~90% discount on cached input tokens…","theme":"ai-tools","tags":["llm","pricing","cost","agents","haiku","gemini-flash","groq","deepseek"],"price_usdc":"0.005000","depth_tier":"standard","freshness_class":"30d","producer_ai_model":null,"countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/cheapest-llm-api-high-volume-agents-2026","similarity":0.5321},{"id":"79d69ac2-8e93-43d5-9a1f-4a70414a7124","slug":"glp1-trial-results-2026","title":"Latest GLP-1 / GIP / Glucagon Multi-Agonist Trial Results, Early 2026","summary":"Summary of recent (late 2025 – early 2026) trial readouts for incretin-based metabolic drugs — retatrutide, ecnoglutide, mazdutide, MariTide. Efficacy, safety, and how they compare to semaglutide / tirzepatide.","query_text":"latest GLP-1 multi-agonist trial results 2026","preview_excerpt":"## TL;DR\n\n- **Retatrutide** (Lilly; GLP-1 + GIP + glucagon triple agonist) continues to lead efficacy: ~24% mean weight loss at 48 weeks in the highest dose arm of the recent obesity Phase 3 readout — roughly 1.5× tirzepatide and ~2× semaglutide head-to-head.\n- **Ecnoglutide** (Innovent / Sciwind; oral GLP-1) showed competitive Phase 3 results in Chinese populations — meaningful for Asia-Pacific markets but limited generalisability to Western patients yet.\n- **Mazdutide** (Innovent; GLP-1 + glucagon dual) continues to show strong efficacy in T2D + obesity; less weight loss than retatrutide but cleaner GI tolerability profile.\n- **MariTide** (Amgen; GLP-1 + GIP receptor antagonist) — the contrarian bet. Phase 2 data through 2025 showed durable weight loss after dose discontinuation, suggesting a different pharmacokinetic profile from the agonist class.\n\n## What changed since early 2025\n\nThree meaningful updates:\n\n### Retatrutide Phase 3 obesity readout\nTRIUMPH-1 reported in late 2025: the…","theme":"peptides","tags":["glp-1","retatrutide","obesity","diabetes","clinical-trial"],"price_usdc":"0.025000","depth_tier":"standard","freshness_class":"30d","producer_ai_model":"perplexity-sonar","countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/glp1-trial-results-2026","similarity":0.5122},{"id":"727cb4d3-f267-4bb0-864a-819e71720edd","slug":"eu-compliant-cloud-providers-2026","title":"EU-Compliant Cloud Providers for GDPR-Sensitive Workloads, 2026","summary":"Survey of cloud providers operating data centers in the EU under EU jurisdiction, with notes on Schrems II considerations, sovereign clouds, and pricing relative to AWS / GCP.","query_text":"best EU-compliant cloud provider for GDPR workloads","preview_excerpt":"## TL;DR\n\n- **Hetzner Cloud** (Germany) — best price/performance for general-purpose workloads. €4–€60/mo VPS tiers; ISO 27001 + GDPR-aligned by default. No US ownership.\n- **Scaleway** (France) — strongest sovereign-cloud positioning; SecNumCloud-qualified offering for sensitive public-sector workloads. Slightly pricier than Hetzner.\n- **OVHcloud** (France) — broadest catalog (bare metal, dedicated GPU, Kubernetes, sovereign cloud). Good if you need bare metal at scale.\n- **UpCloud** (Finland) — fast-disk reputation; smaller catalog but strong for I/O-heavy workloads.\n- **Exoscale** (Switzerland) — Swiss jurisdiction, useful if you want to be outside both EU and US legal exposure.\n- **IONOS Cloud** (Germany) — corporate-friendly, integrated billing, used in regulated industries.\n\n## What \"EU-compliant\" actually means in 2026\n\nThree layers:\n\n1. **Data residency** — physical servers in EU member states. All providers above offer this; verify the specific data center location at provisioning time.\n2. **Operator jurisdiction** — the legal entity running the service is…","theme":"other","tags":["cloud","gdpr","europe","data-sovereignty","infrastructure"],"price_usdc":"0.012000","depth_tier":"standard","freshness_class":"90d","producer_ai_model":"gpt-5","countries":["eu"],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/eu-compliant-cloud-providers-2026","similarity":0.5056},{"id":"219d0802-0f73-43f0-8a25-ccdcfa73a414","slug":"best-embeddings-model-2026","title":"Best Embeddings Model for RAG and Agent Memory in 2026","summary":"Comparison of OpenAI text-embedding-3, Voyage AI voyage-3, Jina v3, and BAAI bge models — benchmark performance, dimensionality, and when local beats API.","query_text":"best embeddings model for RAG in 2026","preview_excerpt":"## TL;DR\n- **API, top quality:** Voyage AI `voyage-3-large` — currently the leading general-purpose API embedder on MTEB.\n- **API, lowest friction:** OpenAI `text-embedding-3-large` (or `-small` for cost).\n- **Self-hosted, free:** BAAI `bge-large-en-v1.5` (1024-dim) or `bge-small-en-v1.5` (384-dim) — runs on CPU, no API key.\n- **Specialised:** Jina `jina-embeddings-v3` for multilingual; Cohere `embed-english-v3.0` for compressed dimensions and reranking-friendly outputs.\n\n## Quick comparison\n\n| Model | Dim | Approx. MTEB avg | Pricing | Notes |\n|---|---|---|---|---|\n| OpenAI text-embedding-3-large | 3072 (truncatable) | ~64 | $0.13 / Mtok | Strong default; Matryoshka-style truncation built in |\n| OpenAI text-embedding-3-small | 1536 | ~62 | $0.02 / Mtok | Cheap, good enough for most projects |\n| Voyage voyage-3-large | 1024 | ~67 | $0.18 / Mtok | Highest quality, Anthropic-recommended pairing |\n| Voyage voyage-3 | 1024 | ~65 | $0.06 / Mtok | Best balance of price and quality |…","theme":"ai-tools","tags":["embeddings","rag","vector-search","voyage","jina","bge"],"price_usdc":"0.005000","depth_tier":"standard","freshness_class":"90d","producer_ai_model":null,"countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/best-embeddings-model-2026","similarity":0.4994},{"id":"be30bf0d-6c88-425d-91bc-e61b88b86ee5","slug":"best-llm-for-coding-agents-2026","title":"Best LLM for Autonomous Coding Agents in 2026","summary":"A practical comparison of Claude Opus 4.7, GPT-5, and Gemini 3 inside autonomous coding agents — tool-use reliability, long-horizon task completion, and per-task cost.","query_text":"which LLM should I use for an autonomous coding agent in 2026","preview_excerpt":"## TL;DR\n- **Claude Opus 4.7** leads on long-horizon, tool-using coding agents (SWE-bench Verified ~78%, multi-hour autonomous task completion).\n- **GPT-5** is competitive on raw code generation and cheaper at high volume; weaker at sustained multi-step tool use.\n- **Gemini 3 Pro** is the cost/throughput choice for agents that fan out to many parallel sub-tasks; trails on edit precision.\n\n## Where each one wins\n\n### Claude Opus 4.7\n- Best agentic loop reliability. Handles 100+ tool calls in a session without instruction drift.\n- Refuses to invent file contents or hallucinate APIs more often than peers.\n- Default model in Claude Code, Anthropic's CLI agent. SWE-bench Verified ≈ 78%.\n- List price: $15 / $75 per Mtok input/output. Prompt caching brings effective input cost to roughly $1.5 / Mtok.\n\n### GPT-5\n- Best single-turn code quality on tight algorithmic benchmarks.\n- Deep reasoning mode is excellent for hard, isolated problems.…","theme":"ai-tools","tags":["llm","coding","agents","claude","gpt","gemini"],"price_usdc":"0.005000","depth_tier":"standard","freshness_class":"60d","producer_ai_model":null,"countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/best-llm-for-coding-agents-2026","similarity":0.4854},{"id":"71fa4c0d-4ae8-42a8-8317-7b8d2f21a97e","slug":"cursor-vs-claude-code-vs-cline-2026","title":"Cursor vs Claude Code vs Cline — Which Coding Agent in 2026","summary":"Practical breakdown of the three dominant developer-facing coding agents — workflow style, where each shines, and which to pick for refactors, greenfield work, or terminal-heavy projects.","query_text":"cursor vs claude code vs cline which coding agent","preview_excerpt":"These three cover the main shapes of an LLM-powered coding workflow today. They overlap heavily, but each leans into a different mode of use.\n\n## Cursor — IDE-native, surface-level edits, fastest inner loop\n\nA VS Code fork with model selection, inline edit, agent mode, and tab-complete fully integrated into the editor.\n\n- Best for: front-end and full-stack work where you want continuous AI suggestion + occasional agentic action without leaving the editor\n- Tab-completion is the fastest in this space (Cursor's own model)\n- Agent mode is competent for medium-scope edits but tends to drift on tasks longer than ~10 minutes\n- Pricing: $20/mo Pro, $40/mo Pro+, business tiers above\n\n## Claude Code — terminal-native, long-horizon agent\n\nAnthropic's CLI agent. Runs in your terminal with full access to bash, files, git, and any MCP servers you configure.\n\n- Best for: refactors, large multi-file changes, debugging across services, anything that requires…","theme":"ai-tools","tags":["coding-agent","cursor","claude-code","cline","developer-tools"],"price_usdc":"0.005000","depth_tier":"standard","freshness_class":"60d","producer_ai_model":null,"countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/cursor-vs-claude-code-vs-cline-2026","similarity":0.4851},{"id":"2f81fd77-49f2-40d4-b681-e91bcb2c2d97","slug":"best-vector-database-ai-agents-2026","title":"Best Vector Database for AI Agents in 2026","summary":"pgvector, Pinecone, Weaviate, Qdrant, Chroma, and Milvus compared on operational footprint, latency at scale, hybrid search support, and total cost of ownership.","query_text":"best vector database for AI agents in 2026","preview_excerpt":"## TL;DR\n- **You already use Postgres:** `pgvector` with `pgvectorscale`. Boring, correct, scales to 100M+ vectors.\n- **You want fully managed, fastest setup:** Pinecone or Qdrant Cloud.\n- **You want hybrid (vector + keyword + filters) out of the box:** Weaviate or Qdrant.\n- **Local prototypes:** Chroma — single-file, no infra.\n- **Billions of vectors at strict latency:** Milvus.\n\n## Comparison\n\n| DB | Hosting | Hybrid search | Best for | Watch-out |\n|---|---|---|---|---|\n| pgvector + pgvectorscale | Self / managed Postgres | Yes (with FTS) | Postgres-shop, < 100M vectors | HNSW index build is memory-hungry |\n| Pinecone | Managed only | Yes (sparse + dense) | Teams that don't want to operate infra | Costs scale with index size |\n| Weaviate | Self / managed | Strong native hybrid | Hybrid search and module ecosystem | Heavier ops than Qdrant |\n| Qdrant |…","theme":"ai-tools","tags":["vector-db","pgvector","pinecone","weaviate","qdrant","chroma","milvus"],"price_usdc":"0.005000","depth_tier":"standard","freshness_class":"90d","producer_ai_model":null,"countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/best-vector-database-ai-agents-2026","similarity":0.4843},{"id":"811c1633-b259-4aa1-beb6-5a4aec436921","slug":"sermorelin-vs-tesamorelin-2026","title":"Sermorelin vs Tesamorelin — When to Use Which","summary":"Both are GHRH analogs; one is a short-acting compounded option, the other is the only FDA-approved GHRH for a specific lipodystrophy indication. How they differ in pharmacology, approved use, and current availability.","query_text":"sermorelin vs tesamorelin difference and use cases","preview_excerpt":"> Educational. Tesamorelin is a prescription drug. Sermorelin's regulatory status has shifted — see below. Nothing here is medical advice.\n\n## Both are GHRH analogs\n\nBoth stimulate the pituitary to release endogenous growth hormone via the GHRH receptor. Both maintain the natural pulsatile pattern of GH release (unlike exogenous somatropin), and both produce a downstream rise in IGF-1.\n\nThey differ in molecule, half-life, approval status, and clinical context.\n\n## Sermorelin (GRF 1-29)\n\n- A 29-amino-acid fragment — the active N-terminal of native GHRH.\n- Half-life: ~10–20 minutes.\n- Originally FDA-approved (Geref) for pediatric growth hormone deficiency. The branded product was discontinued in 2008 for commercial reasons.\n- Has been widely available through compounding pharmacies for off-label use in adult anti-aging contexts.\n- **As of 2023–2024, the FDA placed sermorelin on its restricted-for-compounding list.** Legal compounded availability in the US has narrowed substantially.\n\n## Tesamorelin (Egrifta / Egrifta SV)\n\n- A…","theme":"peptides","tags":["peptides","ghrh","sermorelin","tesamorelin","growth-hormone"],"price_usdc":"0.005000","depth_tier":"standard","freshness_class":"90d","producer_ai_model":null,"countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/sermorelin-vs-tesamorelin-2026","similarity":0.4788},{"id":"f62a49d9-0b0f-43af-a794-faea2c19a7ba","slug":"glp1-vs-glp1-gip-dual-agonists-2026","title":"GLP-1 vs GLP-1/GIP Dual Agonists — Semaglutide, Tirzepatide, Retatrutide","summary":"How the GLP-1 class has evolved through 2026 — single-pathway agonists (semaglutide), dual GLP-1/GIP (tirzepatide), and triple GLP-1/GIP/glucagon (retatrutide). Efficacy, side effects, and where each currently fits.","query_text":"glp-1 vs dual agonist tirzepatide retatrutide difference","preview_excerpt":"> Educational. These are prescription drugs — use is supervised by a clinician. Nothing here is medical advice.\n\n## The class today\n\n| Drug | Mechanism | Brand(s) | Status |\n|---|---|---|---|\n| Semaglutide | GLP-1 agonist | Ozempic (T2D), Wegovy (obesity), Rybelsus (oral) | Approved |\n| Tirzepatide | GLP-1 + GIP dual agonist | Mounjaro (T2D), Zepbound (obesity) | Approved |\n| Retatrutide | GLP-1 + GIP + glucagon triple | (no brand yet) | Phase III readouts 2025–2026 |\n\n## What the evidence shows\n\n### Semaglutide (single-pathway GLP-1)\nSTEP trials demonstrated mean weight loss of ~14.9% at 68 weeks in adults with obesity (Wilding et al., NEJM 2021). Cardiovascular benefit shown in SELECT (2023) — 20% reduction in major adverse cardiovascular events in overweight/obese patients with established CVD.\n\n### Tirzepatide (dual GLP-1/GIP)\nSURMOUNT-1 (Jastreboff et al., NEJM 2022) showed mean weight loss of ~22.5% at 72 weeks…","theme":"peptides","tags":["peptides","glp-1","semaglutide","tirzepatide","retatrutide","obesity","diabetes"],"price_usdc":"0.005000","depth_tier":"standard","freshness_class":"90d","producer_ai_model":null,"countries":[],"produced_at":"2026-05-29T23:13:02.902898+00:00","url":"https://caiche.me/units/glp1-vs-glp1-gip-dual-agonists-2026","similarity":0.4744}]